-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Olema Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to Q3 2025.
- Olema Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$42.2M, a 22.2% decline year-over-year.
- Olema Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$150M, a 22.2% decline year-over-year.
- Olema Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$129M, a 34% decline from 2023.
- Olema Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$96.7M, a 7.76% increase from 2022.
- Olema Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$105M, a 47.4% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)